semaglutide and cardiovascular Semaglutide: What impact does it really have on heart health? Semaglutide protects the heart beyond

Orforgliprons Phase 3 ATTAIN-MAINTAIN trial specifically demonstrated that patients could successfully transition from injectable GLP-1s to orforglipron and maintain their weight loss

What to do: Continue the protocols that got you through weeks 6-7 even though you feel better

No genetic baseline included

Patch testing on the inner forearm before facial application is advisable when reintroducing

Consistent with this, hepatocyte-specific overexpression of DPP4 in mice results in increased hepatic steatosis, liver enzymes, and markers of inflammation (25)

It basically interferes with how the natural FOXO4 protein normally operates